HEALTH A reasoning model hit 88.6% diagnostic accuracy on clinicopathological cases. In the same window, a five-hosp…+ HEALTH A reasoning model reached 88.6% exact or near-exact accuracy on clinicopathological cases.+ EDUCATION Small-scale district pilots report gains for students who previously had no outside tutoring access. POLICY Post-market monitoring standards for clinical AI tools remain unsettled as clearances accelerate. LABOR The labor market's two truths: large projected role creation and concentrated, measurable displacement. LABOR Employment for coders aged 22–25 has fallen roughly 20% against its late-2022 peak.+ LABOR New AI-adjacent skills already carry wage premiums in 1 of every 10 job postings in advanced economies. LABOR Current estimates vary 5x depending on methodology.
Sunday, July 12, 2026
TruvaceThe trace, not the pitch
TRV-2026-0016Certified recordPeer-reviewed

966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study

Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...

Other · General · certified 2026-07-11 · v1 · article view · machine-readable

Current reading — gain

Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...

What this doesn’t fix

Machine-ingested summary: the claims above reflect a single primary source and have not been weighed against contradicting evidence by a Truvace editor yet.

Evidence

Cite this record

Truvace Impact Record TRV-2026-0016, v1: “966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study.” Truvace, 2026-07-11. /record/TRV-2026-0016 (accessed at citation time). sha256 52cd993d5c940295

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv152cd993d5c94

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0016 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.